Alkner, S <br/><br/>
Prognostic and predictive importance of the estrogen receptor coactivator AIB1 in a randomized trial comparing adjuvant letrozole and tamoxifen therapy in postmenopausal breast cancer: the Danish cohort of BIG 1-98.  [electronic resource] 

 -  Breast cancer research and treatment  Nov 2017 
 - 481-490 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1573-7217 
<br/><br/><label>Standard No.: </label>10.1007/s10549-017-4416-0  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Biomarkers, Tumor--metabolism<br/>Breast Neoplasms--drug therapy<br/>Double-Blind Method<br/>Female<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Letrozole<br/>Neoplasm Grading<br/>Nitriles--administration & dosage<br/>Nuclear Receptor Coactivator 3--metabolism<br/>Postmenopause<br/>Prognosis<br/>Tamoxifen--administration & dosage<br/>Tissue Array Analysis--methods<br/>Treatment Outcome<br/>Triazoles--administration & dosage<br/>Up-Regulation